Oncology and Hematologic Malignancies
At Hospital Santa Maria Della Misericordia, a major share of research focuses on neoplasms and blood cancers, with studies in non-small cell lung cancer, melanoma, lymphoma, leukemia, multiple myeloma, and breast cancer. The trials are largely aimed at testing new cancer therapies, improving treatment combinations, and understanding how to better control disease recurrence and progression.
- Research in advanced and resected lung cancer, including targeted and immunotherapy approaches
- Studies in acute myeloid leukemia, acute lymphoblastic leukemia, and other leukemias with risk-adapted treatment strategies
- Trials in lymphoma, multiple myeloma, and related hematologic cancers to improve response and durability of benefit
- Investigations in melanoma and breast cancer focused on better disease control after standard treatment
Overall, the site supports a broad and active oncology program that combines precision medicine, immunotherapy, and new treatment options for both solid tumors and blood cancers.
Cardiovascular and Metabolic Research
The site also conducts important trials in cardiovascular diseases and nutritional and metabolic diseases, especially heart failure, atrial fibrillation, atherosclerotic cardiovascular disease, type 2 diabetes, obesity, and elevated lipoprotein(a). These studies aim to evaluate whether newer treatments can reduce complications, improve long-term outcomes, and lower the burden of chronic disease.
- Trials in heart failure and related cardiovascular conditions to reduce events and improve clinical stability
- Research on atrial fibrillation and coronary disease to refine prevention and treatment strategies
- Studies in obesity, type 2 diabetes, and lipid disorders to address cardiometabolic risk
- Work on lipoprotein(a) and atherosclerosis to better understand cardiovascular risk reduction
This therapeutic area reflects a strong interest in long-term disease prevention and in treatments that can support better heart and metabolic health.
Neurology, Eye Disease, and Immune-Mediated Conditions
Clinical research at the site spans nervous system diseases, eye diseases, and immune system diseases, including Alzheimer’s disease, migraine, multiple sclerosis, age-related macular degeneration, atopic dermatitis, prurigo nodularis, and rheumatoid arthritis. The purpose of these trials is often to improve symptom control, slow disease worsening, or test new options for chronic inflammatory and degenerative disorders.
- Studies in Alzheimer’s disease and cognitive impairment focused on slowing decline and supporting brain health
- Trials for migraine and headache disorders aimed at prevention and better symptom relief
- Research in age-related macular degeneration and other eye conditions to preserve vision
- Immune and inflammatory disease studies in atopic dermatitis, rheumatoid arthritis, and related skin and joint disorders
Within the Department of Medicine and Surgery, this work highlights a broad commitment to improving both quality of life and disease control in chronic conditions.
Respiratory, Skin, and Multisystem Disease Studies
The research portfolio at Hospital Santa Maria Della Misericordia also includes respiratory tract diseases, skin and connective tissue diseases, and other complex inflammatory conditions such as idiopathic pulmonary fibrosis, small-cell lung cancer, hidradenitis suppurativa, acne vulgaris, and systemic sclerosis. These trials are designed to evaluate new therapies, improve disease management, and address conditions with limited treatment options.
- Research in idiopathic pulmonary fibrosis aimed at slowing lung function decline
- Studies in small-cell lung cancer and other respiratory cancers to improve treatment effectiveness
- Trials in hidradenitis suppurativa, acne vulgaris, and related skin disorders to reduce inflammation and symptoms
- Investigations in systemic sclerosis and other multisystem immune conditions to better manage chronic disease burden
With many investigators contributing across these areas, the site supports a diverse portfolio that connects oncology, inflammation, and chronic organ disease research.
